CAR T-cell Therapy or Stem Cell Transplant: New Research on Pediatric Hematological Malignancies
A special issue of Children (ISSN 2227-9067). This special issue belongs to the section "Pediatric Hematology & Oncology".
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 301
Special Issue Editor
Interests: acute leukemias; stem cell transplanation; CAR-T therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are excited to announce a Special Issue of the journal focused on CART therapy in pediatric practice. We invite you to submit original research, reviews, and case reports on the use of CART in the treatment of relapsed or refractory COVID-19-positive leukemias and lymphomas.
CART therapy has revolutionized immunotherapy in the last decade, with a higher impact in pediatric practice, B precursor ALL being the most frequent malignant disease in this population. CART therapy has shown promising results in improving the outcome of patients with relapsed/refractory B ALL. With the advancement of technology and the introduction of new CART products, there is an increasing interest in the use of CART therapy in pediatric hematology.
We welcome contributors that highlight innovative approaches, challenges and outcomes related to the use of CART in pediatric practice. Your submission could significantly contribute to the understanding and advancement of this field.
We look forward to your contributions,
Dr. Anca Colita
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Children is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- children
- acute leukemia
- lymphoma
- CAR-T therapy
